Novimmune Completes CHF30 Million ($29.8 Million) Funding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Novimmune Completes CHF30 Million ($29.8 Million) Funding Round With Existing Shareholders

GENEVA, SWITZERLAND--(Marketwired - Jan 11, 2016) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory and rare diseases, immune-related disorders and cancer, today announced it has completed a CHF30 million ($29.8 million) funding round.

"We are delighted to have completed a CHF30 million funding round driven by major commitments from our lead investors that secured broad participation from our existing shareholder base," said Novimmune Chairman and Chief Executive Officer Eduard Holdener. "This support from our shareholders demonstrates the confidence they have in the strength of our pipeline and in the future of the Company. We remain committed to further developing novel medicines to provide improved treatment options for patients suffering from rare and devastating diseases like Hemophagocytic Lymphohistiocytosis (HLH ) , as well as autoimmune and inflammatory diseases, and cancer."

About Novimmune

Novimmune SA is a privately held, Swiss biopharmaceutical company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer. The company is headquartered in Geneva. More information is available on the company website at www.novimmune.com .

Contact: Eduard Holdener +41 22 839 71 41 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ex-Army Officer Questions Faith in New Book

Updated Category News Views 35

A New Take on Age-Old Questions Diving into religion and philosophy from a combat veteran's perspective isn't your usual day job, but heck, Joe A. Putnam decided to tackle it head-on. In his latest book, "Hey God…Are You Still There?" Putnam doesn't just ponder whether the man upstairs is listening—he's challenging us all to think about it. Exploring Faith Through...

Continue Reading
Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 100

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading
Moody's Boosts Danaos Outlook, Debt Rating Upgrade

Updated Category News Views 24

A Shot of Confidence for Danaos Here's one to mull over—Moody's just gave Danaos Corporation a well-deserved pat on the back. With a nudge in the right direction, they've switched up the outlook on Danaos' Ba1 Corporate Family Rating from stable to positive. Not only that, but they've given a thumbs up to their senior unsecured notes, bumping them from Ba2 to Ba1. Why...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 96

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 51

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 107

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 35

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Dudley DeBosier Lends a Hand with Thanksgiving Giveaway

Updated Category News Views 60

Small Gestures Making a Big Difference Ah, Thanksgiving—a time of turkey, stuffing, and cranberries, with grocery receipts long enough to make your eyes water. And wouldn't you know, Dudley DeBosier Injury Lawyers is stepping in with a little relief, dishing out $2,000 in gift cards. This Louisiana-based law firm is giving away ten $200 gift cards to residents just in...

Continue Reading
Ouma Connect Streamlines Surrogacy Medical Clearance

Updated Category News Views 177

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

Continue Reading
Cognizant & EBRD Unite for Tech Transformation Push

Updated Category News Views 164

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Protis Global's Strategic Leadership Move with Skye Miller

Updated Category News Views 260

Protis Global Elevates Skye Miller as EVP of Fulfillment Protis Global, a leading executive search and advisory firm renowned for its expertise in the consumer packaged goods (CPG) sector, has recently appointed Skye Miller as the Executive Vice President of Sales Fulfillment. Skye, who has been a Partner within the firm, is set to leverage her vast experience to drive...

Continue Reading
Cleveland-Cliffs Reports Strong Q3 2025 Earnings Amid Steel Demand

Updated Category News Views 207

Cleveland-Cliffs Achieves Notable Q3 2025 Earnings Cleveland-Cliffs, Inc. (NYSE: CLF) has announced impressive financial results for the third quarter of 2025, highlighting a significant rebound in domestic steel demand, particularly within the automotive sector. The company's performance signals a growing confidence in its operations, driven by strict pricing agreements...

Continue Reading
IMF Advocates Sustained Tight Monetary Policy in Turkey

Updated Category News Views 192

IMF's Recommendations for Turkey's Monetary Policy The International Monetary Fund (IMF) has strongly advised that Turkey maintain a tight, data-driven monetary policy until the nation’s inflation rate aligns with its established target. This conclusion comes after the completion of an Article IV consultation, highlighting the importance of stable economic practices....

Continue Reading
Insights on Earnings Expectations for Halozyme Therapeutics

Updated Category News Views 138

Earnings Forecast for Halozyme Therapeutics Halozyme Therapeutics (NASDAQ: HALO) is gearing up for its quarterly earnings announcement, and investors eagerly await this revelation. As analysts prepare their assessments, here's what you should know to stay informed. Analyst Expectations Analysts anticipate Halozyme Therapeutics will report an earnings per share (EPS) of...

Continue Reading
Roundhill Investments Celebrates $7 Billion in AUM Growth

Updated Category News Views 239

Roundhill Investments Reaches New Milestone Roundhill Investments, a prominent player in the exchange-traded fund (ETF) arena, has recently achieved a remarkable milestone of $7 billion in assets under management (AUM). This impressive accomplishment reflects the increasing demand for dynamic ETF products that cater to an evolving investment landscape. Innovative ETF...

Continue Reading